Signaling Pathways - Calcium-Activated Potassium (KCa) Channels - NUAK1 - Purinergic (P2Y) Receptors - Angiotensin AT1 Receptors
清除全部
-
B1374 WZ4003Target: NUAK1|NUAK2Summary: NUAK1/2抑制剂 -
B4634 AZD1283Target: Purinergic (P2Y) ReceptorsSummary: P2Y12拮抗剂 -
B2191 Dequalinium Chloride中文名: 地喹氯铵Target: PKC|Calcium-Activated Potassium (KCa) ChannelsSummary: PKC抑制剂 -
B2214 Valsartan中文名: 缬沙坦Target: Angiotensin AT1 ReceptorsSummary: 血管紧张素II AT1受体拮抗剂 -
B1007 AVE 09911 CitationTarget: Angiotensin AT1 ReceptorsSummary: 血管紧张素-（1-7）受体激动剂 -
B2210 Azilsartan中文名: 阿齐沙坦Target: Angiotensin AT1 ReceptorsSummary: 强效血管紧张素II 1型（AT1）受体反向激动剂 -
A5970 Irbesartan中文名: 安博维，厄贝沙坦Target: Angiotensin AT1 ReceptorsSummary: 血管紧张素II抑制剂 -
A5354 Zonisamide中文名: 唑尼沙胺Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Carbonic Anhydrases|Calcium-Activated Potassium (KCa) ChannelsSummary: 抗惊厥和机械效应的抗癫痫药 -
A1888 TRAM-34Target: Calcium-Activated Potassium (KCa) ChannelsSummary: KCa3.1阻断剂 -
A3635 MRT67307 HClTarget: TBK1|MARK1|NUAK1Summary: SIK/TBK-1/IKKe抑制剂